New Drug Approvals Archive - April 2011
Get news by email or subscribe to our news feeds.
See also: New Indications and Dosage Forms for April 2011
April 2011
Caprelsa (vandetanib) Tablets
Date of Approval: April 6, 2011
Company: AstraZeneca
Treatment for: Thyroid Cancer
Caprelsa (vandetanib) is a kinase inhibitor indicated for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable (non-operable) locally advanced or metastatic disease.
Horizant (gabapentin enacarbil) Extended Release Tablets - formerly Solzira
Date of Approval: April 6, 2011
Company: GlaxoSmithKline and XenoPort, Inc.
Treatment for: Restless Legs Syndrome, Postherpetic Neuralgia
Horizant (gabapentin enacarbil) is a gabapentin prodrug indicated for the once-daily treatment of restless legs syndrome and postherpetic neuralgia.
Duexis (famotidine and ibuprofen) Tablets
Date of Approval: April 23, 2011
Company: Horizon Pharma, Inc.
Treatment for: Osteoarthritis, Rheumatoid Arthritis, NSAID-Induced Ulcer Prophylaxis
Duexis (ibuprofen and famotidine) is an NSAID and histamine H2-receptor antagonist combination indicated for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis and to decrease the risk of developing upper GI ulcers.
Zytiga (abiraterone) Tablets
Date of Approval: April 28, 2011
Company: Centocor Ortho Biotech Inc.
Treatment for: Prostate Cancer
Zytiga (abiraterone acetate) is a CYP17 inhibitor indicated for the treatment of patients with metastatic castration-resistant prostate cancer and metastatic high-risk castration-sensitive prostate cancer.
New Drug Approvals Archive
2019January, February, March, April, May, June, July, August, September
2018January, February, March, April, May, June, July, August, September, October, November, December
2017January, February, March, April, May, June, July, August, September, October, November, December
2016January, February, March, April, May, June, July, August, September, October, November, December
2015January, February, March, April, May, June, July, August, September, October, November, December
2014January, February, March, April, May, June, July, August, September, October, November, December
2013January, February, March, April, May, June, July, August, September, October, November, December
2012January, February, March, April, May, June, July, August, September, October, November, December
2011January, February, March, April, May, June, July, August, October, November, December
2010January, February, March, April, May, June, July, August, September, October, November, December
2009January, February, March, April, May, June, July, August, September, October, November, December
2008January, February, March, April, May, June, July, August, September, October, November, December
2007January, February, March, April, May, June, July, August, September, October, November, December
2006January, February, March, April, May, June, July, August, September, October, November, December
2005January, February, March, April, May, June, July, August, September, October, November, December
2004January, February, March, April, May, June, July, August, September, October, November, December
2003January, February, March, April, May, June, July, August, September, October, November, December
2002January, February, April, May, July, August, October, November, December
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
